OncoImmunology 期刊简介

OncoImmunology
英文简介:

Tumor immunology deals with the natural or therapy-induced recognition of cancers, as well as with the intricate interplay between oncogenesis, inflammation and immunosurveillance. We now create a new, high-profile journal, OncoImmunology, that specifically deals with tumor immunology. Recent progress has allowed for the first clinical demonstration (and FDA approval) of anticancer immunotherapies. There is also an ever growing suspicion that - unexpectedly - many of the currently used chemotherapeutic agents depend in their efficacy on the active contribution of immune effectors. To use a drastic metaphor, oncologists who applied successful chemotherapeutic (or radiotherapeutic) regimens have taken advantage of the immune system's capacity to recognize tumor-specific or tumor-associated antigens and to control cancer (stem) cell growth, without being aware of the invisible helping hands. As a result, immunological biomarkers are becoming ever more important to determine the prognosis of cancers and to predict the efficacy of chemotherapies. There is also a strong rationale in favor of combining conventional anticancer therapies with immunotherapies.
OncoImmunology will accept high-profile submissions in the fundamental, translational and clinical areas of tumor immunology. Submissions dealing with solid or hematological cancers, inflammation, innate and acquired immune responses will be welcome.

中文简介:(来自Google、百度翻译)

肿瘤免疫学涉及自然或治疗诱导的癌症识别,以及肿瘤发生,炎症和免疫监视之间的复杂相互作用。现在,我们创建了一个新的,备受瞩目的杂志《肿瘤免疫学》,专门研究肿瘤免疫学。最近的进展使抗癌免疫疗法的首次临床示范 (和FDA批准) 成为可能。人们也越来越怀疑,出乎意料的是,许多目前使用的化学治疗剂的功效取决于免疫效应物的积极作用。用一个激烈的比喻,应用成功的化疗 (或放射治疗) 方案的肿瘤学家已经利用免疫系统识别肿瘤特异性或肿瘤相关抗原并控制癌症 (干细胞) 细胞生长的能力,而没有意识到无形的帮助之手。结果,免疫生物标志物对于确定癌症的预后和预测化学疗法的疗效变得越来越重要。支持将常规抗癌疗法与免疫疗法相结合的理由也很充分。
肿瘤免疫学将在肿瘤免疫学的基础,转化和临床领域接受备受瞩目的论文。涉及实体或血液癌症,炎症,先天和后天免疫反应的提交将受到欢迎。

官方内部论文预审系统 :
1-3天杂志社编辑直接预审
预审通过后100%接收,2022年11月即可录用

微信扫码咨询

期刊ISSN
2162-402X
影响指数
8.029
最新CiteScore值
11.50 查看CiteScore评价数据
最新自引率
4.60%
期刊官方网址

hot

https://www.peipusci.com/?type=9
期刊加急投稿网址

hot

https://www.peipusci.com/?type=10
通讯地址
530 WALNUT STREET, STE 850, PHILADELPHIA, USA, PA, 19106
偏重的研究方向(学科)
ONCOLOGYIMMUNOLOGY-IMMUNOLOGY
出版周期
出版年份
0
出版国家/地区
UNITED STATES
是否OA
No
SCI期刊coverage
Science Citation Index Expanded(科学引文索引扩展)
NCBI查询
PubMed Central (PMC)链接 全文检索(pubmed central)
OncoImmunology 期刊中科院JCR 评价数据
最新中科院JCR分区
大类(学科)
小类(学科)
综述期刊
医学
IMMUNOLOGY(免疫学)2区 ONCOLOGY(肿瘤学)2区
最新的影响因子
8.029
最新公布的期刊年发文量
年度总发文量 研究类文章占比
245 91.02%
总被引频次 49
影响因子趋势图
近年的影响因子趋势图(整体平稳趋势)
OncoImmunology 期刊CiteScore评价数据
最新CiteScore值
11.50
年文章数 245
SJR
3.049
SNIP
1.218
CiteScore排名
序号 类别(学科) 排名 百分位
1 Medicine Oncology #28/340
2 Medicine Immunology and Allergy #22/182
3 Medicine Immunology #27/202
CiteScore趋势图
CiteScore趋势图
OncoImmunology 相关期刊推荐
本刊同领域相关期刊
期刊名称 IF值
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY 2.026
AIDS 4.135
APMIS 3.173
VACCINE 3.605
BIODRUGS 5.749
IMMUNITY 31.428
LYMPHOLOGY 1.273
Lancet HIV 12.639
AIDS REVIEWS 2.475
本刊同分区等级的相关期刊
期刊名称 IF值
AIDS 4.135
BIODRUGS 5.749
OncoImmunology 8.029
TRANSPLANTATION 4.89
JOURNAL OF IMMUNOLOGY 5.368
Advances in Immunology 3.508
Frontiers in Immunology 7.485
INTERNATIONAL IMMUNOLOGY 4.775
JOURNAL OF IMMUNOTHERAPY 4.411
OncoImmunology 投稿经验(由下方点评分析获得,0人参与,3992人阅读)
投稿录用比例: 0.020500
审稿速度: 24 Weeks
分享者 点评内容
没有更多了~
Copyright © 2014-2019 晟斯医学 All Rights Reserved. 备案号:苏ICP备11037034号-5 版权所有:南京孜文信息咨询有限公司